Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22326924 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Vaccine and Antibody Treatment of Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Biological: PROSTVAC-V/TRICOM;   Biological: PROSTVAC-F/TRICOM;   Drug: MDX-010;   Drug: Sargramostim

Indicates status has not been verified in more than two years